Corporate action, page-13

First 13 Last

Share
Profile

Follow
Havenots

662 Posts.

515

03/05/24

16:24

Post #: 73655341
Share

Originally posted by Densy: ↑

It seems the heat has been turned up on the PAA BOD.

I have been made aware that a letter has been sent to the BOD by a SH with a substantial holding putting them on notice over recent events.

As I understand it, the letter seeks a more fulsome explanation from the BOD in relation to its handling of the recent (current/ongoing!) situation and proposes a corporate restructure that includes the replacement of several of the current directors. It is also proposed to reappoint Dr Michael Thurn to a lead role in order to regain lost momentum, ensure the continued execution of the strategic plan he has established and to confidently take MPL forward through the next pivotal round of trialling, regulatory approvals and on to a commercial outcome.

I feel sure that there will be more known about this sooner rather than later, but it certainly sounds like we are approaching a transformational juncture in the life of PAA.

From where I sit – and I’ve been quiet on this until now – it’s difficult to put into words how poorly the situation has been handled by the company. While I don’t possess sufficient information about what precipitated MT’s departure, what I have seen from the company since the announcement of his resignation tells me that the old PAA playbook has been dusted off, which is nothing short of alarming.

I’ve read many comments on HC from a broad range of SH over the past week and half that tell me people are unhappy.

It will be interesting to see what the response is – from SH and the BOD – to this latest development.

Cheers

Densy

Expand

Great news Densy!

It'll be fantastic to have Michael back leading the charge.

A rejuvenation is likely just what PharmAust needs to step into this new chapter effectively.

That is not to discount the efforts of the current board in getting us to this point, but perhaps it's time for them to recognise that a fresh, enthusiastic Board could be the key to propelling us forward and optimising returns for all involved.

Best wishes to everyone involved.

Havelots

PAA Price at posting: 22.0¢ Sentiment: Buy Disclosure: Held
22 Upvote

0 Great analysis

Reply

Top Stories

What's causing the cost-of-living crisis, and how to navigate it

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins